NCT00316784View on ClinicalTrials.gov

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

PHASE3CompletedINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

May 31, 2006

Conditions
Osteoarthritis; Knee
Interventions
DRUG

IDEA-033 (and rescue medication)

Sponsors

Lead Sponsor

IDEA AG
All Listed Sponsors
lead

IDEA AG

INDUSTRY

NCT00316784 - IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA | Biotech Hunter | Biotech Hunter